|
|
Article: Harlan Waksal Resigns; Focus At ImClone Squarely On Erbitux.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Washington Editor
WASHINGTON - The Waksal brothers era at ImClone Systems Inc. is over, following the resignation of Harlan Waksal Monday as chief scientific officer and director.
"We hope ImClone is free of the negativity at this point in time, but how the stock will perform will hinge on both the near-term and long-term future of Erbitux," Cory Kasimov, an analyst with Ryan Beck & Co. in New York, told BioWorld Today. "Investors may perceive it as a positive, that neither of the Waksal brothers is with the company, but then again, it is the Waksal brothers who got Erbitux to the point it is today."
Harlan took over as CEO after his brother, ...
Related newspaper, magazine, and journal articles:
|
|
Article: SAMUEL WAKSAL - IMCLONE SYSTEMS INC (IMCL).
Wall Street Transcript Digest;
January 13, 2000 ;
492 words
...(JAB267) SAMUEL WAKSAL, CEO of IMCLONE SYSTEMS INC (IMCL), describes the company's business and its background; prospects for the industry, with ...
|
|